Literature DB >> 22284677

SUMO-specific protease 1 is critical for early lymphoid development through regulation of STAT5 activation.

Thang Van Nguyen1, Pornpimon Angkasekwinai, Hong Dou, Feng-Ming Lin, Long-Sheng Lu, Jinke Cheng, Y Eugene Chin, Chen Dong, Edward T H Yeh.   

Abstract

Small ubiquitin-like modifier (SUMO) modification has emerged as an important regulatory mechanism during embryonic development. However, it is not known whether SUMOylation plays a role in the development of the immune system. Here, we show that SUMO-specific protease 1 (SENP1) is essential for the development of early T and B cells. STAT5, a key regulator of lymphoid development, is modified by SUMO-2 and is specifically regulated by SENP1. In the absence of SENP1, SUMO-2 modified STAT5 accumulates in early lymphoid precursors, resulting in a block in its acetylation and subsequent signaling. These results demonstrate a crucial role of SENP1 in the regulation of STAT5 activation during early lymphoid development.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22284677      PMCID: PMC3269036          DOI: 10.1016/j.molcel.2011.12.026

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  46 in total

1.  Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro.

Authors:  Thomas M Schmitt; Juan Carlos Zúñiga-Pflücker
Journal:  Immunity       Date:  2002-12       Impact factor: 31.745

Review 2.  PIAS/SUMO: new partners in transcriptional regulation.

Authors:  D Schmidt; S Müller
Journal:  Cell Mol Life Sci       Date:  2003-12       Impact factor: 9.261

Review 3.  Stats: transcriptional control and biological impact.

Authors:  David E Levy; J E Darnell
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

Review 4.  SUMO and ubiquitin in the nucleus: different functions, similar mechanisms?

Authors:  Grace Gill
Journal:  Genes Dev       Date:  2004-09-01       Impact factor: 11.361

Review 5.  Transcriptional control of early B cell development.

Authors:  Meinrad Busslinger
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

6.  Acetylation modulates prolactin receptor dimerization.

Authors:  Li Ma; Jin-song Gao; Yingjie Guan; Xiaoyan Shi; Hao Zhang; Marina K Ayrapetov; Zhe Zhang; Li Xu; Young-Min Hyun; Minsoo Kim; Shougang Zhuang; Y Eugene Chin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-20       Impact factor: 11.205

7.  Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1.

Authors:  Ville Hietakangas; Johanna K Ahlskog; Annika M Jakobsson; Maria Hellesuo; Niko M Sahlberg; Carina I Holmberg; Andrey Mikhailov; Jorma J Palvimo; Lila Pirkkala; Lea Sistonen
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

8.  PIAS proteins promote SUMO-1 conjugation to STAT1.

Authors:  Daniela Ungureanu; Sari Vanhatupa; Noora Kotaja; Jie Yang; Saara Aittomaki; Olli A Jänne; Jorma J Palvimo; Olli Silvennoinen
Journal:  Blood       Date:  2003-07-10       Impact factor: 22.113

9.  Differentiation of B lymphocytes from hematopoietic stem cells.

Authors:  Paulo Vieira; Ana Cumano
Journal:  Methods Mol Biol       Date:  2004

10.  SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation.

Authors:  Richard S Rogers; Curt M Horvath; Michael J Matunis
Journal:  J Biol Chem       Date:  2003-05-22       Impact factor: 5.157

View more
  54 in total

Review 1.  STAT signaling in polycystic kidney disease.

Authors:  Sebastian Strubl; Jacob A Torres; Alison K Spindt; Hannah Pellegrini; Max C Liebau; Thomas Weimbs
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

Review 2.  Protein sumoylation in brain development, neuronal morphology and spinogenesis.

Authors:  Carole Gwizdek; Frédéric Cassé; Stéphane Martin
Journal:  Neuromolecular Med       Date:  2013-08-02       Impact factor: 3.843

3.  p97/VCP promotes degradation of CRBN substrate glutamine synthetase and neosubstrates.

Authors:  Thang Van Nguyen; Jing Li; Chin-Chun Jean Lu; Jennifer L Mamrosh; Gang Lu; Brian E Cathers; Raymond J Deshaies
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-20       Impact factor: 11.205

4.  DeSUMOylation of Gli1 by SENP1 Attenuates Sonic Hedgehog Signaling.

Authors:  Huaize Liu; Sen Yan; Jie Ding; Ting-Ting Yu; Steven Y Cheng
Journal:  Mol Cell Biol       Date:  2017-08-28       Impact factor: 4.272

5.  SENP1 regulates IFN-γ-STAT1 signaling through STAT3-SOCS3 negative feedback loop.

Authors:  Tingting Yu; Yong Zuo; Rong Cai; Xian Huang; Shuai Wu; Chenxi Zhang; Y Eugene Chin; Dongdong Li; Zhenning Zhang; Nansong Xia; Qi Wang; Hao Shen; Xuebiao Yao; Zhong-Yin Zhang; Song Xue; Lei Shen; Jinke Cheng
Journal:  J Mol Cell Biol       Date:  2017-04-01       Impact factor: 6.216

Review 6.  Regulation of T cell receptor complex-mediated signaling by ubiquitin and ubiquitin-like modifications.

Authors:  Samantha F Friend; Francina Deason-Towne; Lisa K Peterson; Allison J Berger; Leonard L Dragone
Journal:  Am J Clin Exp Immunol       Date:  2014-12-05

7.  SUMO-specific protease 1 regulates mitochondrial biogenesis through PGC-1α.

Authors:  Rong Cai; Tingting Yu; Chao Huang; Xuefeng Xia; Xiaobing Liu; Jianmin Gu; Song Xue; Edward T H Yeh; Jinke Cheng
Journal:  J Biol Chem       Date:  2012-11-14       Impact factor: 5.157

Review 8.  Deubiquitinating enzymes as promising drug targets for infectious diseases.

Authors:  Bindu Nanduri; Akamol E Suvarnapunya; Malabi Venkatesan; Mariola J Edelmann
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 9.  Regulation of STAT signaling by acetylation.

Authors:  Shougang Zhuang
Journal:  Cell Signal       Date:  2013-05-22       Impact factor: 4.315

10.  An electrophoretic mobility shift assay identifies a mechanistically unique inhibitor of protein sumoylation.

Authors:  Yeong Sang Kim; Katelyn Nagy; Samantha Keyser; John S Schneekloth
Journal:  Chem Biol       Date:  2013-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.